Immuno Oncology Assays Market 2027 By Technology, Indication, Application and Geography | The Insight Partners

Immuno Oncology Assays Market to 2027 - Global Analysis and Forecasts By Technology ( Immunoassays, PCR, NGS, Flow Cytometry, Others ); Indication ( Colorectal Cancer, Lung Cancer, Melanoma, Bladder Cancer, Others ); Application ( Clinical Diagnostics, Research ), and Geography

Report Code: TIPRE00006575 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
MARKET INTRODUCTION

Immuno oncology assays includes the use of various immunology assays that are used to monitor the interaction between immune cells and cancer cells. The immune system of human body has a great potential to destroy tumor cells producing no toxicity to normal cells. Moreover, the immune system also has an ability to prevent recurrence of cancer.

MARKET DYNAMICS

The immuno oncology assays market is expected to grow exponentially in the forecast period owing to the factors such as increasing number of cancer prevalence, patient preference towards immunotherapies and immunodiagnostics due to side effects of radiation and chemotherapy and technological advances in the immuno oncology assays. Furthermore, high potential growth from emerging nations is anticipated to offer significant growth opportunities in the market during the forecast period.

MARKET SCOPE

The "Global Immuno Oncology Assays Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a particular focus on the global market trend analysis. The report aims to provide an overview of the immuno oncology assays market with detailed market segmentation by technology, Indication, application, and geography. The global immuno oncology assays market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading immuno oncology assays market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global immuno oncology assays market is segmented on the basis of technology, Indication, and application. Based on technology, the market is classified as immunoassays, PCR, NGS, flow cytometry, and others. Based on indication, the market is classified as colorectal cancer, lung cancer, melanoma, bladder cancer, and others. On the basis of application the immuno oncology assays market is classified as clinical diagnostics, and research.

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global immuno oncology assays market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The immuno oncology assays market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting immuno oncology assays market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the immuno oncology assays market in these regions.

MARKET PLAYERS


The reports cover key developments in the immuno oncology assays market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from immuno oncology assays market are anticipated to lucrative growth opportunities in the future with the rising demand for immuno oncology assays market in the global market. Below mentioned is the list of few companies engaged in the immuno oncology assays market.

The report also includes the profiles of key immuno oncology assays market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Agilent Technologies, Inc.
  •  F. Hoffmann-La Roche Ltd
  •  HTG Molecular Diagnostics, Inc.
  •  Illumina, Inc.
  •  Merck KGaA
  •  PerkinElmer Inc.
  •  Thermo Fisher Scientific Inc.
  •  Qiagen
  •  Sartorius AG
  •  NanoString Technologies, Inc.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Immuno Oncology Assays Market - By Technology
1.3.2 Immuno Oncology Assays Market - By Indication
1.3.3 Immuno Oncology Assays Market - By Application
1.3.4 Immuno Oncology Assays Market - By Region
1.3.4.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. IMMUNO ONCOLOGY ASSAYS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. IMMUNO ONCOLOGY ASSAYS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. IMMUNO ONCOLOGY ASSAYS MARKET - GLOBAL MARKET ANALYSIS
6.1. IMMUNO ONCOLOGY ASSAYS - GLOBAL MARKET OVERVIEW
6.2. IMMUNO ONCOLOGY ASSAYS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. IMMUNO ONCOLOGY ASSAYS MARKET - REVENUE AND FORECASTS TO 2027 - TECHNOLOGY
7.1. OVERVIEW
7.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
7.3. IMMUNOASSAYS
7.3.1. Overview
7.3.2. Immunoassays Market Forecast and Analysis
7.4. PCR
7.4.1. Overview
7.4.2. PCR Market Forecast and Analysis
7.5. NGS
7.5.1. Overview
7.5.2. NGS Market Forecast and Analysis
7.6. FLOW CYTOMETRY
7.6.1. Overview
7.6.2. Flow Cytometry Market Forecast and Analysis
7.7. OTHERS
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis

8. IMMUNO ONCOLOGY ASSAYS MARKET - REVENUE AND FORECASTS TO 2027 - INDICATION
8.1. OVERVIEW
8.2. INDICATION MARKET FORECASTS AND ANALYSIS
8.3. COLORECTAL CANCER
8.3.1. Overview
8.3.2. Colorectal Cancer Market Forecast and Analysis
8.4. LUNG CANCER
8.4.1. Overview
8.4.2. Lung Cancer Market Forecast and Analysis
8.5. MELANOMA
8.5.1. Overview
8.5.2. Melanoma Market Forecast and Analysis
8.6. BLADDER CANCER
8.6.1. Overview
8.6.2. Bladder Cancer Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. Others Market Forecast and Analysis

9. IMMUNO ONCOLOGY ASSAYS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. CLINICAL DIAGNOSTICS
9.3.1. Overview
9.3.2. Clinical Diagnostics Market Forecast and Analysis
9.4. RESEARCH
9.4.1. Overview
9.4.2. Research Market Forecast and Analysis

10. IMMUNO ONCOLOGY ASSAYS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Immuno Oncology Assays Market Overview
10.1.2 North America Immuno Oncology Assays Market Forecasts and Analysis
10.1.3 North America Immuno Oncology Assays Market Forecasts and Analysis - By Technology
10.1.4 North America Immuno Oncology Assays Market Forecasts and Analysis - By Indication
10.1.5 North America Immuno Oncology Assays Market Forecasts and Analysis - By Application
10.1.6 North America Immuno Oncology Assays Market Forecasts and Analysis - By Countries
10.1.6.1 United States Immuno Oncology Assays Market
10.1.6.1.1 United States Immuno Oncology Assays Market by Technology
10.1.6.1.2 United States Immuno Oncology Assays Market by Indication
10.1.6.1.3 United States Immuno Oncology Assays Market by Application
10.1.6.2 Canada Immuno Oncology Assays Market
10.1.6.2.1 Canada Immuno Oncology Assays Market by Technology
10.1.6.2.2 Canada Immuno Oncology Assays Market by Indication
10.1.6.2.3 Canada Immuno Oncology Assays Market by Application
10.1.6.3 Mexico Immuno Oncology Assays Market
10.1.6.3.1 Mexico Immuno Oncology Assays Market by Technology
10.1.6.3.2 Mexico Immuno Oncology Assays Market by Indication
10.1.6.3.3 Mexico Immuno Oncology Assays Market by Application
10.2. EUROPE
10.2.1 Europe Immuno Oncology Assays Market Overview
10.2.2 Europe Immuno Oncology Assays Market Forecasts and Analysis
10.2.3 Europe Immuno Oncology Assays Market Forecasts and Analysis - By Technology
10.2.4 Europe Immuno Oncology Assays Market Forecasts and Analysis - By Indication
10.2.5 Europe Immuno Oncology Assays Market Forecasts and Analysis - By Application
10.2.6 Europe Immuno Oncology Assays Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Immuno Oncology Assays Market
10.2.6.1.1 Germany Immuno Oncology Assays Market by Technology
10.2.6.1.2 Germany Immuno Oncology Assays Market by Indication
10.2.6.1.3 Germany Immuno Oncology Assays Market by Application
10.2.6.2 France Immuno Oncology Assays Market
10.2.6.2.1 France Immuno Oncology Assays Market by Technology
10.2.6.2.2 France Immuno Oncology Assays Market by Indication
10.2.6.2.3 France Immuno Oncology Assays Market by Application
10.2.6.3 Italy Immuno Oncology Assays Market
10.2.6.3.1 Italy Immuno Oncology Assays Market by Technology
10.2.6.3.2 Italy Immuno Oncology Assays Market by Indication
10.2.6.3.3 Italy Immuno Oncology Assays Market by Application
10.2.6.4 Spain Immuno Oncology Assays Market
10.2.6.4.1 Spain Immuno Oncology Assays Market by Technology
10.2.6.4.2 Spain Immuno Oncology Assays Market by Indication
10.2.6.4.3 Spain Immuno Oncology Assays Market by Application
10.2.6.5 United Kingdom Immuno Oncology Assays Market
10.2.6.5.1 United Kingdom Immuno Oncology Assays Market by Technology
10.2.6.5.2 United Kingdom Immuno Oncology Assays Market by Indication
10.2.6.5.3 United Kingdom Immuno Oncology Assays Market by Application
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Immuno Oncology Assays Market Overview
10.3.2 Asia-Pacific Immuno Oncology Assays Market Forecasts and Analysis
10.3.3 Asia-Pacific Immuno Oncology Assays Market Forecasts and Analysis - By Technology
10.3.4 Asia-Pacific Immuno Oncology Assays Market Forecasts and Analysis - By Indication
10.3.5 Asia-Pacific Immuno Oncology Assays Market Forecasts and Analysis - By Application
10.3.6 Asia-Pacific Immuno Oncology Assays Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Immuno Oncology Assays Market
10.3.6.1.1 Australia Immuno Oncology Assays Market by Technology
10.3.6.1.2 Australia Immuno Oncology Assays Market by Indication
10.3.6.1.3 Australia Immuno Oncology Assays Market by Application
10.3.6.2 China Immuno Oncology Assays Market
10.3.6.2.1 China Immuno Oncology Assays Market by Technology
10.3.6.2.2 China Immuno Oncology Assays Market by Indication
10.3.6.2.3 China Immuno Oncology Assays Market by Application
10.3.6.3 India Immuno Oncology Assays Market
10.3.6.3.1 India Immuno Oncology Assays Market by Technology
10.3.6.3.2 India Immuno Oncology Assays Market by Indication
10.3.6.3.3 India Immuno Oncology Assays Market by Application
10.3.6.4 Japan Immuno Oncology Assays Market
10.3.6.4.1 Japan Immuno Oncology Assays Market by Technology
10.3.6.4.2 Japan Immuno Oncology Assays Market by Indication
10.3.6.4.3 Japan Immuno Oncology Assays Market by Application
10.3.6.5 South Korea Immuno Oncology Assays Market
10.3.6.5.1 South Korea Immuno Oncology Assays Market by Technology
10.3.6.5.2 South Korea Immuno Oncology Assays Market by Indication
10.3.6.5.3 South Korea Immuno Oncology Assays Market by Application
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Immuno Oncology Assays Market Overview
10.4.2 Middle East and Africa Immuno Oncology Assays Market Forecasts and Analysis
10.4.3 Middle East and Africa Immuno Oncology Assays Market Forecasts and Analysis - By Technology
10.4.4 Middle East and Africa Immuno Oncology Assays Market Forecasts and Analysis - By Indication
10.4.5 Middle East and Africa Immuno Oncology Assays Market Forecasts and Analysis - By Application
10.4.6 Middle East and Africa Immuno Oncology Assays Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Immuno Oncology Assays Market
10.4.6.1.1 South Africa Immuno Oncology Assays Market by Technology
10.4.6.1.2 South Africa Immuno Oncology Assays Market by Indication
10.4.6.1.3 South Africa Immuno Oncology Assays Market by Application
10.4.6.2 Saudi Arabia Immuno Oncology Assays Market
10.4.6.2.1 Saudi Arabia Immuno Oncology Assays Market by Technology
10.4.6.2.2 Saudi Arabia Immuno Oncology Assays Market by Indication
10.4.6.2.3 Saudi Arabia Immuno Oncology Assays Market by Application
10.4.6.3 U.A.E Immuno Oncology Assays Market
10.4.6.3.1 U.A.E Immuno Oncology Assays Market by Technology
10.4.6.3.2 U.A.E Immuno Oncology Assays Market by Indication
10.4.6.3.3 U.A.E Immuno Oncology Assays Market by Application
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Immuno Oncology Assays Market Overview
10.5.2 South and Central America Immuno Oncology Assays Market Forecasts and Analysis
10.5.3 South and Central America Immuno Oncology Assays Market Forecasts and Analysis - By Technology
10.5.4 South and Central America Immuno Oncology Assays Market Forecasts and Analysis - By Indication
10.5.5 South and Central America Immuno Oncology Assays Market Forecasts and Analysis - By Application
10.5.6 South and Central America Immuno Oncology Assays Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Immuno Oncology Assays Market
10.5.6.1.1 Brazil Immuno Oncology Assays Market by Technology
10.5.6.1.2 Brazil Immuno Oncology Assays Market by Indication
10.5.6.1.3 Brazil Immuno Oncology Assays Market by Application
10.5.6.2 Argentina Immuno Oncology Assays Market
10.5.6.2.1 Argentina Immuno Oncology Assays Market by Technology
10.5.6.2.2 Argentina Immuno Oncology Assays Market by Indication
10.5.6.2.3 Argentina Immuno Oncology Assays Market by Application

11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

12. IMMUNO ONCOLOGY ASSAYS MARKET, KEY COMPANY PROFILES
12.1. AGILENT TECHNOLOGIES, INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. F. HOFFMANN-LA ROCHE LTD
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. HTG MOLECULAR DIAGNOSTICS, INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. ILLUMINA, INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. MERCK KGAA
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. PERKINELMER INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. THERMO FISHER SCIENTIFIC INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. QIAGEN
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. SARTORIUS AG
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. NANOSTRING TECHNOLOGIES, INC.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments

13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Agilent Technologies, Inc.
2. F. Hoffmann-La Roche Ltd
3. HTG Molecular Diagnostics, Inc.
4. Illumina, Inc.
5. Merck KGaA
6. PerkinElmer Inc.
7. Thermo Fisher Scientific Inc.
8. Qiagen
9. Sartorius AG
10. NanoString Technologies, Inc.